Targeting key DDR protein kinases such as ATR (which targets HR), ATM, and DNA-PKcs (which target NHEJ) has also been effective in enhancing the response of HNSCC cells to photon radiation [46], and some of these agents are currently in clinical trials. This evidence concerns the gene PRKDC and head and neck squamous cell carcinoma.